Title: Travis T Wager, et al. Discovery of two clinical histamine H(3) receptor antagonists: trans-N-ethyl-3-fluoro-3--fluoro-4-(pyrrolidinylmethyl)phenylcyclobutanecarboxamide (PF-03654746) and trans-3-fluoro-3--fluoro-4-(pyrrolidin-1-ylmethyl)phenyl-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764). J Med Chem. 2011 Nov 10;54(21):7602-20.
Title: Michelle L North, et al. Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit. Allergy Asthma Clin Immunol. 2014 Jul 3;10(1):33.